PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹383 Cr | ₹75 Cr | ₹-26 Cr | ₹-88 Cr | ₹-1,613 Cr |
What is the latest Net Cash Inflow / Outflow ratio of PFIZER ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹383 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹-26 Cr |
| Mar2022 | ₹-88 Cr |
| Mar2021 | ₹-1,613 Cr |
How is Net Cash Inflow / Outflow of PFIZER Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹383 Cr | 408.05 | |
| Mar2024 | ₹75 Cr | Positive | |
| Mar2023 | ₹-26 Cr | Negative | |
| Mar2022 | ₹-88 Cr | Negative | |
| Mar2021 | ₹-1,613 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,741.3 Cr | -2.4% | -5.2% | -5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -2.4% |
-5.2% |
-5.3% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses